financetom
Business
financetom
/
Business
/
ODDITY Tech Shares Rise After Q1 Results Beat Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ODDITY Tech Shares Rise After Q1 Results Beat Estimates
May 8, 2024 10:42 AM

01:24 PM EDT, 05/08/2024 (MT Newswires) -- ODDITY Tech ( ODD ) shares were up 14% in recent Wednesday trading after the company's Q1 results surpassed estimates.

The company reported Q1 adjusted diluted earnings late Tuesday of $0.61 per share, up from $0.37 a year earlier.

Analysts polled by Capital IQ expected $0.49.

Revenue for the quarter ended March 31 was $212 million, up from $166 million a year earlier.

Analysts surveyed by Capital IQ expected $205.2 million.

The firm said it expects Q2 adjusted diluted earnings of $0.61 to $0.64 per share on revenue of $185 million to $189 million.

Analysts surveyed by Capital IQ expected $0.56 per share on revenue of $186.4 million.

The company raised its full-year adjusted EPS guidance to $1.57 to $1.62 on revenue of $626 million to $635 million. Its prior outlook was $1.49 to $1.54 on sales of $620 million to $630 million.

Analysts surveyed by Capital IQ expected $1.51 on revenue of $626.4 million.

Price: 35.80, Change: +4.54, Percent Change: +14.52

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Airbus sees supply progress, Spirit deal to close in fourth quarter
Airbus sees supply progress, Spirit deal to close in fourth quarter
Oct 13, 2025
PARIS (Reuters) -Airbus has seen a marked improvement in confidence and performance from its suppliers, all of whom are ready to support the company's target of increasing deliveries by 7% to some 820 jets this year, a senior company official said on Monday. The European planemaker is also on its way towards a longer-term goal of increasing underlying output of...
AbbVie Gains FDA Approval for Expanded Rinvoq Use in IBD Patients
AbbVie Gains FDA Approval for Expanded Rinvoq Use in IBD Patients
Oct 13, 2025
11:24 AM EDT, 10/13/2025 (MT Newswires) -- AbbVie ( ABBV ) said Monday that the US Food and Drug Administration approved an updated Rinvoq indication for adults with moderately to severely active ulcerative colitis and Crohn's disease. The updated label permits Rinvoq use before tumor necrosis factor blockers for patients unsuited to TNF inhibitors who have tried at least one...
American Battery Technology (ABAT) Stock Is Rising: What's Going On?
American Battery Technology (ABAT) Stock Is Rising: What's Going On?
Oct 13, 2025
Shares of American Battery Technology Co ( ABAT ) are trading higher Monday morning after the company announced it has completed a critical step in developing its Tonopah Flats Lithium Project in Nevada. Here’s what investors need to know. What To Know: American Battery ( ABAT ) has finished all required National Environmental Policy Act (NEPA) baseline studies and submitted...
Oklo Stock Surges To New All-Time Highs Monday: What's Driving The Action?
Oklo Stock Surges To New All-Time Highs Monday: What's Driving The Action?
Oct 13, 2025
Shares of Oklo Inc ( OKLO ) soared to a new all-time high Monday morning, continuing a powerful rally fueled by optimistic analyst coverage and increasing demand for clean energy. Here’s what investors need to know. What To Know: The advanced nuclear energy company has gained 1,600% over the past year, driven by the growing need for reliable power for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved